Global Paediatric Vaccine Market, By Vaccine Type (Monovalent and Multivalent), Technology (Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate and Other Technologies), Application (Infectious Disease, Cancer, Allergy, Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR) and Other Applications) – Industry Trends and Forecast to 2029.
Global Paediatric Vaccine Market Analysis and Size
The paediatric vaccines are used to prevent children from contracting several infectious and non-infectious diseases. The prevalence of chronic diseases is escalating the growth of paediatric vaccine market.
Global paediatric vaccine market was valued at USD 35.74 billion in 2021 and is expected to reach USD 68.78 billion by 2029, registering a CAGR of 9.80% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2022 to 2029 |
|
Base Year |
2021 |
|
Historic Years |
2020 (Customizable to 2019 - 2014) |
|
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
|
Segments Covered |
Vaccine Type (Monovalent and Multivalent), Technology (Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate and Other Technologies), Application (Infectious Disease, Cancer, Allergy, Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR)? and Other Applications) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. |
|
Market Players Covered |
Incyte. (US), SINOVAC (China), DAIICHI SANKYO COMPANY, LIMITED. (Japan), Astellas Pharma Inc. (Japan), Novo Nordisk A/S (Denmark), Grifols, S.A. (Spain), Pfizer Inc. (US), Johnson & Johnson Services, Inc. (US), Sanofi (France), Teva Pharmaceutical Industries Ltd. (Jerusalem), Takeda Pharmaceutical Company Limited. (Japan), Astrazeneca (UK), Bristol-Myers Squibb Company (US), GlaxoSmithKline plc (US), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Lily. (US), Abbott (US), Merck & Co., Inc. (US) among others |
|
Market Opportunities |
|
Global Paediatric Vaccine Market Definition
Pediatric vaccines refer to the preparation consisting of dead microorganisms, fully virulent organisms, or live attenuated organisms. They are administered for stimulating the production of antibodies that further provide immunity against one or several diseases among children. Paediatric vaccines are generally utilized in childhood immunization schedules with the purpose of improving child’s immunity or prevent diseases.
Paediatric Vaccine Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
- Prevalence of Various Diseases
The increase in the prevalence of numerous diseases, such as pertussis, influenza, diphtheria, and tetanus, pertussis, among other infectious and non-infectious diseases in children acts as one of the major factors driving the growth of paediatric vaccine market.
- Initiatives by Government
The rise in government and non-government funding for the development of novel vaccines and surge in initiatives for raising awareness regarding immunization accelerate the market growth.
- Global Vaccination Coverage
The surge in uptake of new vaccines has leading to an increase in global vaccination coverage further influence the market.
Opportunities
Furthermore, increase in the number of approvals for vaccines extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Also, advancements in the development of vaccines will further expand the market.
Restraints/Challenges Global Paediatric Vaccine Market
On the other hand, rise in the cost of vaccines and stringent guidelines are expected to obstruct market growth. Also, availability of biosimilars at low rates is projected to challenge the paediatric vaccine market in the forecast period of 2022-2029.
This paediatric vaccine market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on paediatric vaccine market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Patient Derived Xenograft (Pdx) Models Market
COVID-19 had a negative impact on the paediatric vaccine market. Hospital access was restricted to non-essential care, and O&P clinics were temporarily closed during the pandemic. The implementation of social distancing, lockdown of the population and limited access to clinics greatly affected the market. The slow-down in patient flow and referrals also impacted the market growth. However, market will resume its growth in the post-pandemic due to the easing in restrictions that were imposed earlier.
Recent Development
- Pfizer and BioNTech initiated a rolling submission for Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine among children, including 6 months old to 4 years of age in February’2022. The announcement was made following a request from the U.S. Food and Drug Administration (FDA). The decision was made in response to the urgent public health need in this population.
Global Paediatric Vaccine Market Scope and Market Size
The paediatric vaccine market is segmented on the basis of vaccine type, technology and application. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Vaccine Type
- Monovalent
- Multivalent
On the basis of vaccine type, the paediatric vaccine market is segmented into monovalent and multivalent.
Technology
- Live Attenuated
- Inactivated
- Subunit
- Toxoid
- Conjugate
- Other Technologies
On the basis of technology, the paediatric vaccine market is segmented into live attenuated, inactivated, subunit, toxoid, conjugate and other technologies.
Application
- Infectious Disease
- Cancer
- Allergy
- Pneumococcal Disease
- Influenza
- Measles, Mumps, and Rubella (MMR)
- Other Applications
On the basis of application, the paediatric vaccine market is segmented into infectious disease, cancer, allergy, pneumococcal disease, influenza, measles, mumps, and rubella (MMR) and other applications.
Paediatric Vaccine Market Regional Analysis/Insights
The paediatric vaccine market is analysed and market size insights and trends are provided by country, vaccine type, technology and application as referenced above.
The countries covered in the paediatric vaccine market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the paediatric vaccine market because of the surge in research and development investments by numerous companies within the region.
Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2022 to 2029 due to the rise in government support for immunization in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The paediatric vaccine market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for paediatric vaccine market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the paediatric vaccine market. The data is available for historic period 2010-2020.
Competitive Landscape and Paediatric Vaccine Market Share Analysis
The paediatric vaccine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to paediatric vaccine market.
Some of the major players operating in the paediatric vaccine market are:
- Incyte. (US)
- SINOVAC (China),
- DAIICHI SANKYO COMPANY, LIMITED. (Japan)
- Astellas Pharma Inc. (Japan)
- Novo Nordisk A/S (Denmark)
- Grifols, S.A. (Spain)
- Pfizer Inc. (US)
- Johnson & Johnson Services, Inc. (US)
- Sanofi (France)
- Teva Pharmaceutical Industries Ltd. (Jerusalem)
- Takeda Pharmaceutical Company Limited. (Japan)
- Astrazeneca (UK)
- Bristol-Myers Squibb Company (US)
- GlaxoSmithKline plc (US)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Novartis AG (Switzerland)
- Lily (US)
- Abbott (US)
- Merck & Co., Inc., (US)
Research Methodology : Global Paediatric Vaccine Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-pediatric-vaccine-market
SKU-
